Schedule 13G ownership disclosure

SYNERGY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 871639308

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-16-002882
Form type
SC 13G/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub